90 web-programmer-developer-"https:" "https:" "https:" "https:" "https:" "Medical Research Council" positions at Universidade de Coimbra
Sort by
Refine Your Search
-
Development Fund (FEDER), through the Centro Regional Program 2021-2027 (Centro 2030), by Portugal 2030 and by the European Union | Notice Code: Centro2030-2024-59 | Operation code: CENTRO2030-FEDER-02359500
-
, if the latter are not from the desired field of study and/or do not possess the relevant knowledge to develop the work plan. I.II - The non-degree-granting course must be related to the type of activity covered
-
available at http://www.fct.pt/logotipos/ and, when applicable, the logos of the European Union and the Operational Program, following the graphic standards available on the websites of the respective
-
insurance. VI.IV - Funding: The grant(s) assigned under this call will be funded by European Regional Development Fund (FEDER), through the Centro Regional Program 2021-2027 (Centro 2030), by Portugal 2030
-
: 857524), and the Operational Program of the Centro Region of Portugal (CCDRC Ref: CENTRO-45-2020-75), in the conditions described below. The full text of the Call is available at https://www.uc.pt/mia
-
Hours Per Week 35 Is the job funded through the EU Research Framework Programme? Horizon Europe Reference Number 101164313 Is the Job related to staff position within a Research Infrastructure? No Offer
-
Development Fund (ERDF) through the Regional Programme (CENTRO 2030) of Portugal 2030; reference of operation 17321, operation code CENTRO2030-FEDER-01180000 on Balcão dos Fundos. VI.IV - Information and
-
for it, as well as mandatory personal accident insurance. VI.III - Funding: The grant(s) assigned under this call will be funded by European Regional Development Fund (ERDF) through the Regional Programme
-
job funded through the EU Research Framework Programme? Other EU programme Reference Number nr. 16798, COMPETE2030-FEDER-00798200, NeuroinSight - Dissec Is the Job related to staff position within a
-
Plan / Goals to be achieved: The project REVERSE aims to develop a nanoformulation for the delivery of nucleic acids in vivo. This system will explore the use of extracellular vesicles modified with